Harness Biotech Stock Volatility with an Options StrategyCompanies / BioTechAug 13, 2015 – 10:27 PM GMTBy: TLSReportVolatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That’s the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital. Can you grow a portfolio if some of your more successful names […]
Related FOLDMid-Morning Market Update: Markets Gain; Finish Line Beats Q1 ViewsMorning Market GainersRelated IPXLUS Stock Futures Signal Higher Start On Wall StreetImpax Announces Sale of Daraprim to Turing Pharmaceuticals AG , ~$55MAquinox’s Shares Shoot Up, Bladder Pain Drug in Focus(Zacks)In a recent report, analysts at Leerink shared their views on a ton of biotech stocks. Here is a look at […]
Related ALXNUS Stock Futures Drop Ahead Of Economic DataStrensiq Receives Marketing Approval in Japan for Treatment of Patients with HypophosphatasiaBy and large, the number of shares short in the leading biotech and emerging pharmaceutical stocks shrank between the June 15 and June 30 settlement dates.The trend was particularly noticeable in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Gilead Sciences, Inc. (NASDAQ: […]
These Promising Cancer Therapies Are a Biotech Stocks “Triple Play”Companies / BioTechJun 19, 2015 – 03:04 PM GMTBy: Money_MorningErnie Tremblay writes: On Jan. 7, 2015, CytRX Corp. (NASDAQ: CYTR) announced positive results from a study of its experimental brain cancer drug, aldoxorubicin, and the company’s stock immediately jumped 15.8%. Then, over the next four months, it nearly doubled.Over the months […]
Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]
Best Investor Play in the Hottest Biotech Stock Market on EarthCompanies / Tech StocksJun 17, 2015 – 08:01 AM GMTBy: Money_MorningMichael A. Robinson writes: Biotechnology is a big opportunity. And China is a big market.Combine the two and you have a big potential for investment profits.In today’s Strategic Tech Investor, I’m talking with Money Map Press Executive Editor William Patalon […]
In early April I wrote a piece arguing that biotech stocks – using the iShares Nasdaq Biotech ETF (IBB) as a proxy – looked to be under distribution. At the time the IBB traded at approximately $340. My argument rested on negative divergences in the Shares Outstanding / Price action of the IBB, Block Money Flow trends, an increase in volatility, […]
When an already attractive company in the small cap biotech space announces positive developments, it can take the market weeks or even months to price the news into the shares. Bret Jensen identifies three cheap companies with strong catalysts to power the next leg of their rallies.There are few things more exciting than buying a small biotech stock just before […]
For one top technician, there are only two names that matter to the market right now: Apple and biotech.”The correlation between Apple and biotech is outstanding,” technical analyst Carter Worth said Friday on CNBC’s “Options Action.” In what he’s dubbing the “king and queen” of the market, Worth said, “The way the two act, you’d think nothing else in the […]
On the pages of Investors Alley, Bret Jensen has a history of recommending biotech winners. Today, we’re following up on five of Bret’s most promising biotech recommendations that have staged big gains and could still be in the early innings of significant rallies. These stocks are still strong buys.The small biotech sector is one of the most volatile sectors of […]
